Azure Hospice: The Claim Went in Without the Medical Support

Azure Hospice fraud involved approximately $2,266,694 in false Medicare claims for patients who did not qualify for hospice or lacked medical records supporting their eligibility, according to the Justice Department’s account. Medicare paid Azure approximately $2,140,606. The owner knew about the eligibility problems when the claims went in. The cost fell on Medicare, while patients were enrolled in a healthcare benefit they did not qualify for.

Azure Hospice Care Inc. was based in Garden Grove, California. The Department of Justice described an owner who knew either that beneficiaries did not qualify or that their medical records did not sufficiently support the diagnosis and prognosis needed for hospice benefits. It also reported that she did not routinely coordinate with their primary care physicians about their conditions or terminal prognoses.

Admissions, nursing and billing each see a part of this problem: what the patient’s condition showed, what the owner knew and what Medicare was asked to pay.

The Owner’s Role in Admissions and Claims

Azure’s co-owner and operator later became its sole owner. The Justice Department described her submitting claims, and causing claims to be submitted, for people who lacked the required terminal prognosis.

The announcement gives a concrete example. In October 2022, the owner submitted a $6,600 hospice claim while knowing that the beneficiary’s medical records did not adequately establish Medicare hospice eligibility.

The government said the point of the claim was simple: Medicare would rely on the claim that the patient qualified and send payment to Azure.

Who Determines Eligibility for Hospice?

An authorized hospice physician certifies terminal illness, with a qualifying attending physician also certifying the first benefit period when the patient has one. The Medicare certification requirements call for a prognosis of six months or less if the illness runs its normal course, backed by clinical information and a narrative about the individual patient.

Azure’s eligibility problem was already known when the claim went in. The owner did not routinely coordinate with primary care physicians about patients’ conditions or terminal prognoses. The question reaches behind the signature: what information actually reached the people deciding eligibility?

The patient’s health care is at stake too. As the Government Accountability Office’s hospice payment report explains, enrolling in hospice means giving up Medicare payment for treatment aimed at curing the terminal illness. Medicare can still cover unrelated care separately. HHS-OIG has warned that patients enrolled inappropriately may unknowingly forgo treatment they need. A false eligibility decision can change the care available to a patient as well as send money to the hospice.

An Admission Opens the Door to Daily Payments

Medicare generally pays routine home care by the enrolled day, including days without a visit. The Government Accountability Office’s June 2026 report on hospice payment explains that a hospice can make a visit one day and none the next, typically receiving the same daily payment for the day nobody came.

Care costs tend to be highest around admission and near death, with a less costly stretch between them. That payment structure makes the admission decision financially important: once a patient is enrolled, continued days can keep producing revenue even when the work varies.

The HHS Office of Inspector General examined that incentive in its January 2015 report, Medicare Hospices Have Financial Incentives to Provide Care in Assisted Living Facilities. Using Medicare claims from 2007 through 2012, it found that hospices typically supplied fewer than five hours of visits per week to assisted-living beneficiaries receiving routine home care while receiving about $1,100 per week for each beneficiary. Its explanation was blunt:

That assisted-living study explains the business incentive. Azure’s account supplies the patient-eligibility and knowledge facts. Together, they show why the clinical decision belongs in the financial story: the medical support is what justifies access to a benefit that pays for enrolled days.

What the Hospice Put Before the Physician

The information reaching a physician also mattered in the separate qui tam case involving Curo Health Services and Avalon Hospice. In its account of the government’s complaint, the Justice Department alleged that the companies failed to ensure that certifying physicians received or adequately considered complete and accurate information about patients’ conditions.

The whistleblowers who started that case alleged something a clinical employee could recognize immediately:

The alleged notes gave the chart a clinical account from nurses who were away. Azure’s documented problem was different: claims submitted with knowledge that eligibility or its medical support was lacking. Both accounts make the information behind the claim worth examining, including who supplied it and who knew what was missing.

What Evidence Is Needed to Prove Fraud?

For an eligibility case like Azure’s, the useful evidence connects a patient’s condition and supporting medical records to a particular Medicare claim and the knowledge of the person responsible for it. What an insider saw inside admissions or billing helps us understand where that connection broke down.

An admissions worker may know what was missing before enrollment. A nurse may know what the assessment actually showed. A biller may know which claims went out after someone raised an eligibility concern. This is where the patient record meets the Medicare billing record.

You Saw What the Medical Record Was Missing

If you watched a hospice submit claims despite known eligibility gaps, speak to one of our whistleblower experts about the claims that went in without the medical support. We work with hospice whistleblowers to build your strongest hospice whistleblower case, bring in hospice fraud whistleblower lawyers who understand clinical records and Medicare payment, and stay beside you throughout the case. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.